+477
San Francisco Bay Area - California, U.S.A.
Contact this investorsSoftware (Web Marketplace Saas..) • Education • BioTech • CleanTech • Web Security (& Privacy) • Analytics • Logistics (& Distribution) • Medical Devices (& Hospital Services) • Pharmaceutical (& Medicine) • Woman Focused
Most Interested In
We help grow companies See http://a2e.co/
Not Interested In
Real Estate
San Francisco Bay Area - California, U.S.A.
Contact this investorsBioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused
Bio + Health Tech VC supporting Founder-led startups. 3x Founder. 12x exits in life sciences.
Shahram Seyedin-Noor is the Founder and serves as General Partner at Civilization Ventures. Seyedin-Noor is a Co-Founder at Rgenix and previously served as an Advisor. He was previously its Executive Chairman and Chief Business Officer. Prior to Rgenix, Seyedin-Noor was a founding executive at NextBio, a pioneer in genomics data analysis and personalized medicine. NextBio was acquired by Illumina in 2013 (NASDAQ: ILMN). Seyedin-Noor helped grow NextBio into a profitable leader in the life sciences with millions in revenues from top-tier customers such as Merck, Celgene, J&J, Regeneron, Pfizer and nearly every other major biotech/pharma company. He is also an angel investor in various innovative healthcare startups, including Avantome (acq. by Illumina), Bina Technologies (acq. by Roche), Counsyl and Omada Health, among others. Prior to founding Civilization Ventures, Shahram was an entrepreneur and angel investor. Shahram is a founding executive in several life sciences companies, including Rgenix, a biotech company with first-in-class therapeutics for cancer, now in Phase 1 clinical trials. Prior to Rgenix, he was founding CFO and VP of Corporate Development at NextBio, a genomics big data analytics pioneer acquired by Illumina in 2013. Shahram is also a seed investor in category-defining startups such as Omada Health and Counsyl. Shahram began his career in Silicon Valley as startup counsel at Wilson Sonsini Goodrich & Rosati, and later as a high tech investment banker at Goldman Sachs. Shahram earned his JD from Harvard Law School, where he was elected Editor-in-Chief of the Harvard International Law Journal, and obtained a BA in Economics from Pomona College.
New York City - Pennsylvania, U.S.A.
Contact this investorsBioTech • Medical Devices (& Hospital Services) • Pharmaceutical (& Medicine)
Partner, Chief Investment Officer at BioAdvance
Arizona, U.S.A.
Contact this investorsBioTech • Hardware (& Manufacturing) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine)
Managing Partner at AZ-VC
San Francisco Bay Area, U.S.A.
Contact this investorsBioTech • AgroTech • CleanTech • HealthTech (& Fitness) • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine)
We invest in cohorts, up to 15 companies roughly twice per year. We do investments beyond the accelerator into seed, A, and beyond. However that is only for accelerator alum.
, U.S.A.
Contact this investorsBioTech • HealthTech (& Fitness) • Food & Beverage • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused
Managing Partner @ Seaside Ventures
Los Angeles - California, U.S.A. - Canada
Contact this investorsPharmaceutical (& Medicine)
Venture Partner at Palo Santo VC
Previously Investor @structure-capital , @us-navy Pilot, @wharton-school MBA, @united-states-naval-academy Â
Kenya, U.S.A. - Luxembourg
Contact this investorsBioTech • A.I. (& Big Data) • HealthTech (& Fitness) • Impact • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused
Healthcare Investor - Better healthcare for Africa
Former EUR 7.5bn fund of fund investor (European Investment Fund, Luxembourg), Angel, Emerging Market start-up fund manager in Ghana.
San Francisco Bay Area - California, U.S.A.
Contact this investorsBioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine)
Managing Partner at Pivotal BioVentures
Toronto (Ontario) - Toronto (), Canada
Contact this investorsSoftware (Web Marketplace Saas..) • Education • BioTech • Entertainment (& Sports) • Pharmaceutical (& Medicine)
Venture Partner at Golden Ventures
San Francisco Bay Area - California, U.S.A.
Contact this investorsBioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) • Woman Focused
Co-Founder/CSO @endpointhealth frmr Visiting Partner @YCombinator Head of Research @Roche/GeneWEAVE Division Co-Founder/CTO @GeneWEAVE Angel @endpointvc
Founder @geneweave ⢠Studied at @cornell-university, @university-of-california-santa-barbara
Salt Lake City - Utah, U.S.A.
Contact this investorsBioTech • A.I. (& Big Data) • Pharmaceutical (& Medicine)
Co-Founder/CEO Recursion
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment SuccessChatNode.ai: Revolutionizing Communication with AI, A Success StoryInterview with the Founder of ZenLaw: An Angels Partners Success Story!Sell SaaS Success StoryAWA Success StoryAngels Partners helps The MVMNT Group raise $250k for Saas product
